Showing results (191-200 of 212) with videos related to
Sort By:
Pageof 22
Clinical Colorectal Cancer|November 19, 2021
Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal CancerNicolette Taku, Y Nancy Yi-Qian, George J Chang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2019
Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) StudyNilofer S Azad, Robert J Gray, Michael J Overman, et al.Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal AdenocarcinomaAbdelrahman Yousef, Mahmoud Yousef, Mohammad Zeineddine, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2021
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver MetastasesPreeti Kanikarla Marie, Cara Haymaker, Edwin Roger Parra, et al.Molecular Cancer Therapeutics|May 22, 2016
BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics SystemFilip Janku, Helen J Huang, Bart Claes, et al.Cancer|January 26, 2018
Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapyAhmed M Amer, Mohamed Zaid, Baishali Chaudhury, et al.JAMA Oncology|September 12, 2024
Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer SurvivalMahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, et al.Journal for Immunotherapy of Cancer|February 10, 2025
Sex and outcomes of patients with microsatellite instability-high and <i>BRAF</i> V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitorsVincenzo Nasca, Joseph Zhao, Javier Ros, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2025
Histologic- and Genomic-Directed Adjuvant Therapy for Ampullary Adenocarcinoma: A Hidden Genome-Derived AnalysisBrett L Ecker, Kenneth Seier, Ankur Choubey, et al.JAMA Network Open|February 28, 2024
Serum Tumor Markers and Outcomes in Patients With Appendiceal AdenocarcinomaAbdelrahman Yousef, Mahmoud Yousef, Mohammad A Zeineddine, et al.Pageof 22